Status:
RECRUITING
Sentinel Lymph Node in Early-Stage Endometrium Cancer
Lead Sponsor:
Istanbul University
Conditions:
Sentinel Lymph Node
Endometrial Cancer
Eligibility:
FEMALE
18-90 years
Phase:
NA
Brief Summary
The aim of this prospective study is to investigate whether the detection rate of sentinel lymph node (SLN) with double tracer injected at two different sites may be increased compared to the standard...
Detailed Description
Endometrial cancer is the most common gynecologic cancer. Although 85-90% of women are diagnosed at early stage, about 10-15% are diagnosed at advanced stages. Treatment and prognosis depends on the s...
Eligibility Criteria
Inclusion
- Must have preoperative histologic diagnosis of endometrial carcinoma
- Must be in early stage ( stage1 and 2) endometrial carcinoma radiologically and clinically
- Must have written informed consent
Exclusion
- Possible allergic reaction to commonly used drugs
- Medical or surgical contraindications for comphrensive staging
- Preoperative or intraoperative findings of advanced endometrial cancer
Key Trial Info
Start Date :
July 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06163963
Start Date
July 1 2023
End Date
May 1 2026
Last Update
November 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istanbul University Medical Faculty Dept. of Obstet Gynecol, Division of Gynecologic Oncology
Istanbul, Istanbul / Turkey, Turkey (Türkiye), 34093